David Koenig insider trades: ProUroCare Medical (PUMD) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 1, 2010 | PUMD | ↑ Buy | 5,938 | $1.60 | $10K | Direct | Jul 2, 2010 (1d) |
| Sep 29, 2009 | PUMD | ↑ Buy | 4,834 | $1.50 | $7K | Direct | Oct 1, 2009 (2d) |
| Apr 13, 2009 | PUMD | ↑ Buy | 9,798 | $0.74 | $7K | Direct | Apr 15, 2009 (2d) |
| Jul 11, 2008 | PRRC | ↑ Buy | 6,250 | $1.00 | $6K | Direct | Jul 15, 2008 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Koenig's insider trades
David Koenig is a director at ProUroCare Medical (PUMD). Since Jul 11, 2008, David has reported 4 open-market purchases worth $30K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), other transactions (4 filings), option exercises (2 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PUMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.